<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2024.1469805</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening of m6A-associated ferroptosis-related genes in atherosclerosis based on WGCNA</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Meiling</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/2800119/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/></contrib>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Weidong</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/2847683/overview" /><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Liyong</given-names></name><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Zhu</surname><given-names>Guofu</given-names></name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/></contrib>
</contrib-group>
<aff><institution>Cardiology Department, The Second Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming, Yunnan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Gabrielle Fredman, Albany Medical College, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Xiaobo Wang, Columbia University, United States</p>
<p>Dunpeng Cai, University of Missouri, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Guofu Zhu <email>zhuguofu@kmmu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>28</day><month>10</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume><elocation-id>1469805</elocation-id>
<history>
<date date-type="received"><day>24</day><month>07</month><year>2024</year></date>
<date date-type="accepted"><day>10</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Jiang, Zhao, Wu and Zhu.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Jiang, Zhao, Wu and Zhu</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>N6-methyladenosine (m6A) has been shown to mediate ferroptosis but its role in atherosclerosis (AS) is unclear.</p>
</sec><sec><title>Methods</title>
<p>Differentially expressed m6A-associated ferroptosis-related genes (DE-m6A-Ferr-RGs) were obtained using differential expression analysis and Pearson correlation analysis. Weighted gene co-expression network analysis (WGCNA) was also performed. The intersection of the module genes and the DE-m6A-Ferr-RGs were recorded as candidate m6A-Ferr-related signature genes. Finally, the m6A-Ferr-related signature genes were screened using least absolute shrinkage and selection operator (LASSO) analysis. Expression validation, receiver operating characteristic ( mapping, and immune correlation analysis were also performed based on the m6A-Ferr-related signature genes. The expression of m6A-Ferr-related signature genes was further validated using a real-time polymerase chain reaction (RT-qPCR).</p>
</sec><sec><title>Results</title>
<p>In total, 6,167 differentially expressed genes were intersected with 24 m6A- and 259 ferroptosis-related genes, respectively, resulting in 113 DE-m6A-Ferr-RGs obtained using Pearson&#x2019;s correlation analysis. The module genes obtained from the WGCNA and the 113 DE-m6A-Ferr-RGs were intersected to obtain 48 candidate m6A-Ferr-related signature genes. LASSO analysis was performed and six m6A-Ferr-related signature genes were screened. In addition, the area under the curve values of all six m6A-Ferr-related signature genes were greater than 0.7, indicating that they had potential diagnostic value. Furthermore, the RT-qPCR results revealed that the expression of <italic>SLC3A2</italic>, <italic>NOX4</italic>, and <italic>CDO1</italic> was consistent with the transcriptome level. Moreover, there was a significant difference in two types of immune cells between the AS and control groups. Naive B cells, CD8&#x002B; T cells, regulatory T cells, and activated natural killer cells were positively correlated with <italic>CDO1</italic> and <italic>NOX4</italic> but negatively correlated with <italic>ATG7</italic>, <italic>CYBB</italic>, and <italic>SLC3A2</italic>.</p>
</sec><sec><title>Conclusion</title>
<p>In total, three m6A-Ferr-related signature genes (<italic>NOX4</italic>, <italic>CDO1</italic>, and <italic>SLC3A2</italic>) were obtained through a series of bioinformatics analyses and an RT-qPCR.</p>
</sec>
</abstract>
<kwd-group>
<kwd>m6A</kwd>
<kwd>ferroptosis</kwd>
<kwd>m6A-Ferr-related signature genes</kwd>
<kwd>WGCNA</kwd>
<kwd>immune infiltration</kwd>
</kwd-group><contract-num rid="cn001">YNWR-QNBJ-2020-238</contract-num><contract-sponsor id="cn001">Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province</contract-sponsor><counts>
<fig-count count="8"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="46"/><page-count count="14"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Atherosclerosis and Vascular Medicine</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Atherosclerosis (AS) is a common pathological foundation for numerous cardiovascular diseases (CVD) (<xref ref-type="bibr" rid="B1">1</xref>). AS is characterized by a disorder in lipid metabolism, smooth muscle hyperplasia, endothelial dysfunction, apoptosis, necrosis, inflammation, and the formation of foam cells and lipid plaques (<xref ref-type="bibr" rid="B2">2</xref>). In addition, increasing evidence indicates that epigenetic modifications are associated with the onset and progression of AS (<xref ref-type="bibr" rid="B3">3</xref>). N6-methyladenosine (m6A) methylation modification is one of the most prevalent epigenetic alterations in eukaryotic RNA. Dysregulation of m6A modification levels occurs in various pathological and physiological processes, including AS (<xref ref-type="bibr" rid="B4">4</xref>). In recent years, researchers have confirmed that the occurrence and development of AS are closely linked to m6A RNA methylation (<xref ref-type="bibr" rid="B5">5</xref>). For example, m6A methyltransferase <italic>METTL3</italic> promotes angiogenesis and atherosclerosis by upregulating the <italic>JAK2/STAT3</italic> pathway through the m6A reader IGF2BP1 (<xref ref-type="bibr" rid="B4">4</xref>). The lack of <italic>METTL3</italic> in macrophages inhibits the formation of AS plaque induced by hyperlipidemia (<xref ref-type="bibr" rid="B6">6</xref>). Ferroptosis, a newly discovered form of regulatory cell death, is characterized by iron-dependent cell death and excessive lipid peroxidation. Recent studies have indicated that ferroptosis can promote the progression of AS through iron-dependent lipid peroxidation (<xref ref-type="bibr" rid="B7">7</xref>). Various pathological and physiological events related to AS, including disorders in lipid and iron metabolism, oxidative stress, oxidized low-density lipoprotein (Ox-LDL)&#x2013;induced vascular endothelial cell injury, and inflammatory reactions, are associated with ferroptosis (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Furthermore, key regulatory factors of ferroptosis have been found to exhibit abnormal levels of m6A under different pathological conditions (<xref ref-type="bibr" rid="B9">9</xref>). Increasing evidence suggests that m6A modification and m6 regulatory factors play a crucial role in regulating cell susceptibility to ferroptosis (<xref ref-type="bibr" rid="B10">10</xref>). In recent years, numerous studies have demonstrated that m6A modification plays a role in the regulation of ferroptosis and impacts the progression of diseases including cancer (<xref ref-type="bibr" rid="B11">11</xref>), chronic obstructive pulmonary disease (COPD) (<xref ref-type="bibr" rid="B12">12</xref>), liver fibrosis (<xref ref-type="bibr" rid="B13">13</xref>), and aortic dissection (<xref ref-type="bibr" rid="B14">14</xref>). The regulatory factors of m6A modification combined with ferroptosis-related genes can potentially serve as diagnostic or prognostic markers for human tumors (<xref ref-type="bibr" rid="B15">15</xref>). However, the association between m6A-modified ferroptosis and AS has not been thoroughly elucidated.</p>
<p>Therefore, we conducted a study that aimed to identify m6A-related ferroptosis biomarkers during the occurrence and development of AS. We screened for m6A-related ferroptosis diagnostic genes using weighted gene co-expression network analysis (WGCNA), screened for m6A-Ferr-related signature genes using least absolute shrinkage and selection operator (LASSO) regression analysis, and developed a diagnostic risk model for AS that aimed to reveal m6A-related ferroptosis biomarkers in AS.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<sec id="s2a"><label>2.1</label><title>Data sources</title>
<p>AS-related expression profile data were obtained from the Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>). The GSE43292 dataset (arterial tissues from 32 controls and 32 AS patients) was used as the training set and the GSE100927 dataset (arterial tissues from 12 controls and 29 AS patients) was used as the validation set. In total, 259 ferroptosis-related genes (Ferr-RGs) were obtained from the FerrDb database (<ext-link ext-link-type="uri" xlink:href="http://www.zhounan.org/ferrdb/current/">http://www.zhounan.org/ferrdb/current/</ext-link>) (<xref ref-type="bibr" rid="B16">16</xref>) (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>) and 24 m6A regulators were obtained from the literature (<xref ref-type="bibr" rid="B17">17</xref>) (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>).</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Differential expression analysis</title>
<p>To identify the differentially expressed genes (DEGs) between different samples, the data in GSE43292 were analyzed for DEGs associated with AS using the R language &#x201C;limma&#x201D; package (version 3.50.1) (<xref ref-type="bibr" rid="B18">18</xref>) with an adjusted <italic>p</italic>-value (<italic>p</italic><sub>adj</sub>) &#x003C;0.01 as a screening criterion. Volcano and heat maps were plotted using &#x201C;ggplot2&#x201D; (version 3.3.5) and &#x201C;pheatmap&#x201D; (version 1.0.12), respectively.</p>
</sec>
<sec id="s2c"><label>2.3</label><title>Correlation calculation of differentially expressed m6A-associated genes and differentially expressed ferroptosis-related genes</title>
<p>The intersection of DEGs with m6A-related genes (m6A-RGs) was taken to obtain the differentially expressed m6A-associated genes (DE-m6A-RGs), using Venn (version 1.11) (<xref ref-type="bibr" rid="B19">19</xref>) to create the Venn diagrams. Similarly, the differentially expressed ferroptosis-related genes (DE-Ferr-RGs) were obtained. Pearson&#x2019;s correlation was calculated between these genes. Genes that met the criteria (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 and &#x007C;<italic>R</italic>&#x007C;&#x003E;0.4) were recognized as differentially expressed m6A-associated ferroptosis-related genes (DE-m6A-Ferr-RGs), and the results of the calculation were visualized in a heat map.</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Weighted gene co-expression network analysis</title>
<p>To identify genes associated with different traits, WGCNA (version 1.70.3) (<xref ref-type="bibr" rid="B20">20</xref>) was performed on the samples from GSE43292. A hierarchical clustering tree was first constructed for all the samples (<italic>N</italic>&#x2009;&#x003D;&#x2009;64), and a sample dendrogram and a trait (AS vs. control) heat map were constructed. Next, the appropriate soft threshold was selected based on the near-scale-free topological criteria to construct gene modules. The modules were then gathered according to the criteria of the dynamic tree-cut algorithm. The correlations of each gene module with traits (control and AS) were calculated, the conditions for selecting key modules were: non-gray modules, <italic>p</italic>-values &#x003C;0.05, and &#x007C;cor&#x007C; &#x003E;0.5. Finally, module membership (MM) and gene significance (GS) screening were performed, and the key module genes were screened using the criteria of &#x007C;GS&#x007C; &#x003E;0.4 and &#x007C;MM&#x007C; &#x003E;0.8, respectively.</p>
</sec>
<sec id="s2e"><label>2.5</label><title>Functional enrichment analysis</title>
<p>The DE-m6A-Ferr-RGs were intersected with the key module genes to obtain candidate m6A-Ferr-related signature genes. To investigate the biological pathways involving the candidate m6A-Ferr-related signature genes, the Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of the candidate m6A-Ferr-related signature genes were performed using the &#x201C;clusterprofiler&#x201D; package (version 4.2.2) (<xref ref-type="bibr" rid="B21">21</xref>).</p>
</sec>
<sec id="s2f"><label>2.6</label><title>LASSO algorithm model</title>
<p>To further identify m6A-Ferr-related signature genes, LASSO analysis (<xref ref-type="bibr" rid="B22">22</xref>) of the candidate m6A-Ferr-related signature genes was performed using glmnet (version 4.1.2), with the &#x201C;family&#x201D; parameter set as &#x201C;binomial&#x201D; and the cross-validation parameter &#x201C;nfolds&#x201D; adjusted to 10 to obtain the cross-validated error maps and gene coefficient maps. Thus, the m6A-Ferr-related signature genes were finally obtained. Subsequently, expression analysis of the m6A-Ferr-related signature genes was implemented in the GSE43292 and GSE100927 datasets, respectively. Receiver operating characteristic (ROC) curves were drawn using the pROC package (version 2.3.0) (<xref ref-type="bibr" rid="B23">23</xref>) to evaluate the diagnostic value of the m6A-Ferr-related signature genes. The larger the area under the curve (AUC), the higher the accuracy. The R package &#x201C;rms&#x201D; (version 6.2-0) (<xref ref-type="bibr" rid="B24">24</xref>) was used to construct the nomogram to predict the incidence of AS. Calibration curves were plotted using &#x201C;regplot&#x201D; (version 1.1) (<xref ref-type="bibr" rid="B25">25</xref>). Decision curves (DCA) was also plotted using the &#x201C;rmda&#x201D; package.</p>
</sec>
<sec id="s2g"><label>2.7</label><title>Gene Set enrichment analysis</title>
<p>To find the significant pathways for the m6A-Ferr-related signature genes, single-gene gene set enrichment analysis (GSEA) (<xref ref-type="bibr" rid="B26">26</xref>) was performed. The filtering criteria were &#x007C;NES&#x007C; &#x003E;1, <italic>p</italic><sub>adj</sub> &#x003C;0.05, and <italic>q</italic>-value &#x003C;0.25.</p>
</sec>
<sec id="s2h"><label>2.8</label><title>Immuno-infiltration analysis</title>
<p>To investigate whether there were differences in immune cells between the atherosclerosis and control groups, we used the false discovery rate (FDR) correction to calculate the proportion of 22 kinds of immune cells in the AS samples. Heat maps and boxplots were drawn for visualization. Lollipop mapping of the 22 immune cells and m6A-Ferr-related signature genes were plotted to show the correlation analysis result.</p>
</sec>
<sec id="s2i"><label>2.9</label><title>Expression validation of m6A-Ferr-related signature genes</title>
<p>The relative RNA expression level genes were quantified by a real-time polymerase chain reaction procedure. Thus, 12 frozen tissue samples were obtained from the College of Forensic Medicine, Kunming Medical University, of which samples 1&#x2013;5 were the control group and 6&#x2013;12 were the AS group. This study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Kunming Medical University in China. All patients had signed an informed consent form. The expression of m6A-Ferr-related signature genes was further validated via RT-qPCR. The total RNA of the 12 samples was extracted using TRIzol (Ambion, Austin, USA) according to the manufacturer&#x0027;s instructions. Reverse transcription of the total RNA to cDNA was carried out using a SureScript-First-strand-cDNA-synthesis-kit (Servicebio, Wuhan, China) based on the manufacturer&#x0027;s instructions. RT-qPCR was performed utilizing the 2xUniversal Blue SYBR Green qPCR Master Mix (Servicebio, Wuhan, China). The primer sequences for the PCR are shown in <xref ref-type="sec" rid="s10">Supplementary Table S3</xref>. <italic>GAPDH</italic> was used as an internal reference gene. The 2<sup>&#x2212;&#x0394;&#x0394;Ct</sup> method was utilized to calculate the expression of key genes (<xref ref-type="bibr" rid="B27">27</xref>).</p>
</sec>
<sec id="s2j"><label>2.10</label><title>Statistical analysis</title>
<p>All bioinformatics analyses were undertaken in R language. The rank sum test was employed to contrast the data from different groups. <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 was considered to represent a significant difference.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>DE-m6A-Ferr-RGs in the AS samples</title>
<p>The differential analysis obtained a total of 6,167 DEGs in the AS and control samples from the GSE43292 dataset, of which 3,112 genes were upregulated and 3,055 genes were downregulated in the AS samples (<xref ref-type="fig" rid="F1">Figure&#x00A0;1A</xref>). The top 100 upregulated and downregulated genes are presented in a heat map (<xref ref-type="fig" rid="F1">Figure&#x00A0;1B</xref>). The intersection of the DEGs with 24 m6A-RGs and 259 Ferr-RGs resulted in nine DE-m6A-RGs and 104 DE-Ferr-RGs, respectively (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>). The results of the correlation between the DE-m6A-RGs and the DE-Ferr-RGs genes are shown in <xref ref-type="fig" rid="F1">Figure&#x00A0;1D</xref>. In total, 113 genes satisfied <italic>p</italic> &#x003C;0.001 and &#x007C;<italic>R</italic>&#x007C; &#x003E;0.4 and were considered as DE-m6A-Ferr-RGs for subsequent analysis.</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>The DE-m6A-Ferr-RGs in the AS samples according to the differential analysis. <bold>(A)</bold> Volcano map of gene expression in the AS vs. control samples. Blue represents downregulated genes, red represents upregulated genes, and gray represents genes with no significant differential expression. <bold>(B)</bold> Heatmap showing differential gene expression in the AS vs. control samples. <bold>(C)</bold> Venn diagrams of DEGs with m6A-RGs and Ferr-RGs that result in ferroptosis. <bold>(D)</bold> The DE-m6A-RGs and DE-Ferr-RGs correlation heat map.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g001.tif"/>
</fig>
</sec>
<sec id="s3b"><label>3.2</label><title>Screening for candidate m6A-Ferr-related signature genes</title>
<p>WGCNA was performed in the GSE43292 dataset. The hierarchical clustering tree results, as shown in <xref ref-type="fig" rid="F2">Figure&#x00A0;2A</xref>, showed no significant outlier samples, so all samples were used for the subsequent analysis. The clustering and trait heat map of the AS and control samples is shown in <xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>. As shown in <xref ref-type="fig" rid="F2">Figure&#x00A0;2C</xref>, nine with the best soft thresholds were chosen to construct the gene modules, and 23 gene modules were obtained, among which the gray module was non-sense (<xref ref-type="fig" rid="F2">Figure&#x00A0;2D</xref>). The heat map shows the correlation between the 23 gene modules and the AS and control groups (<xref ref-type="fig" rid="F2">Figure&#x00A0;2E</xref>). The key modules associated with AS were the blue, tan, green, yellow, brown, and green modules according to a <italic>p</italic>-value of &#x003C;0.05 and &#x007C;cor&#x007C; of &#x003E;0.5 (<xref ref-type="fig" rid="F2">Figure&#x00A0;2F</xref>). The key module genes were screened using the criteria of &#x007C;GS&#x007C; &#x003E;0.4 and &#x007C;MM&#x007C; &#x003E;0.8, respectively, and a total of 2,373 module genes were obtained (<xref ref-type="fig" rid="F2">Figure&#x00A0;2G</xref>). Finally, the DE-m6A-Ferr-RGs were intersected with the key module genes to obtain 48 candidate m6A-Ferr-related signature genes (<xref ref-type="fig" rid="F2">Figure&#x00A0;2H</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Screening of candidate m6A-Ferr-related signature genes by WGCNA. <bold>(A)</bold> Clustering of samples in the GSE43292 dataset. <bold>(B)</bold> Merged data sample clustering and phenotypic information. <bold>(C)</bold> Distribution of scale-free soft threshold values. <bold>(D)</bold> Tree diagram depicting module clustering. <bold>(E)</bold> Heatmap showing the correlations between modules and clinical traits. <bold>(F)</bold> Number of genes in each module. <bold>(G)</bold> Scatter plot demonstrating the relationship between key modules in MM and GS. <bold>(H)</bold> Venn diagram of DE-m6A-Ferr-RGs and key modular genes.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g002.tif"/>
</fig>
</sec>
<sec id="s3c"><label>3.3</label><title>Enrichment analysis of the candidate m6A-Ferr-related signature genes</title>
<p>To determine the potential biological roles of the selected candidate m6A-Ferr-related signature genes, we performed enrichment analyses. The GO functional enrichment analysis resulted in a total of 295 items, including 250 biological process (BP) items (cellular response to chemical stress, response to oxidative stress, neutrophil degranulation, etc.), 31 cellular components items (tertiary granule, endocytic vesicles, membrane rafts, etc.), and 14 molecular functions items (ubiquitin protein ligase binding, ferrous iron binding, dioxygenase activity, etc.) (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>), and <xref ref-type="fig" rid="F3">Figure&#x00A0;3A</xref> shows the top 10 ranked items under each GO classification. The results of the KEGG pathway analysis showed that a total of 11 pathways were enriched, and the enriched pathways [ferroptosis, autophagy-animal, chemical carcinogenesis-reactive oxygen species (ROS), etc.] are shown in <xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>.</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>GO functional enrichment analysis of candidate m6A-Ferr-related signature genes. <bold>(A)</bold> Bar graph representing the top 10 Gene Ontology enrichments. <bold>(B)</bold> Bubble chart illustrating KEGG pathway enrichments.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g003.tif"/>
</fig>
</sec>
<sec id="s3d"><label>3.4</label><title>Screening for m6A-Ferr-related signature genes</title>
<p>Screening for m6A-Ferr-related signature genes was conducted using LASSO regression analysis. The LASSO analysis screened six genes (<italic>AGPAT3</italic>, <italic>NOX4</italic>, <italic>CDO1</italic>, <italic>CYBB</italic>, <italic>ATG7</italic>, and <italic>SLC3A2</italic>) that were recorded as m6A-Ferr-related signature genes (<xref ref-type="fig" rid="F4">Figures&#x00A0;4A,B</xref>). ROC curves of the LASSO model with AUC values of 0.880 and 0.741 in the GSE43292 dataset and the GSE100927 dataset, respectively (<xref ref-type="fig" rid="F4">Figures&#x00A0;4C,D</xref>), indicated that the model performed well. Thus, a nomogram was plotted based on the six genes. The adjusted C-index of the nomogram was 0.835, indicating that the selection of the genes was appropriate (<xref ref-type="fig" rid="F4">Figure&#x00A0;4E</xref>). The calibration and decision curves confirmed the above conclusion (<xref ref-type="fig" rid="F4">Figures&#x00A0;4F,G</xref>).</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Screening m6A-ferr-related signature gene using LASSO analysis. <bold>(A)</bold> LASSO logistic regression coefficient penalty plot. <bold>(B)</bold> LASSO logic coefficient penalty diagram. <bold>(C)</bold> LASSO model ROC curve in GSE43292 dataset. <bold>(D)</bold> LASSO model ROC curve in GSE100927 dataset. <bold>(E)</bold> Nomogram predicting the incidence rate. <bold>(F)</bold> Column chart correction curve. <bold>(G)</bold> Decision curve for the LASSO model.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g004.tif"/>
</fig>
</sec>
<sec id="s3e"><label>3.5</label><title>Analysis and verification of m6A-Ferr-related signature genes</title>
<p>The expression of the m6A-Ferr-related signature genes in the AS and control samples from GSE43292 is shown in <xref ref-type="fig" rid="F5">Figure&#x00A0;5A</xref>, in which <italic>AGPAT3</italic>, <italic>ATG7</italic>, <italic>CYBB</italic>, and <italic>SLC3A2</italic> were highly expressed and <italic>NOX4</italic> and <italic>CDO1</italic> were slightly expressed in AS group. Furthermore, the expression of the m6A-Ferr-related signature genes was verified in GSE100927. As shown in <xref ref-type="fig" rid="F5">Figure&#x00A0;5C</xref>, the expression trend of the genes in the GSE100927 dataset was completely consistent with the GSE43292 dataset. In addition, in the GSE43292 and GSE100927 datasets, the AUC values of all six m6A-Ferr-related signature genes were greater than 0.7, indicating that they could distinguish AS patients from the control samples and had potential diagnostic value (<xref ref-type="fig" rid="F5">Figures&#x00A0;5B,D</xref>). We collected 12 histological samples for RT-qPCR validation, and the detailed disease information of the corresponding patient samples is presented in <xref ref-type="sec" rid="s10">Supplementary Table S5</xref>. The RT-qPCR results revealed that the expression of <italic>SLC3A2</italic>, <italic>NOX4</italic>, and <italic>CDO1</italic> was consistent with the transcriptome level. The expression trend of <italic>AGPAT3</italic>, <italic>CYBB</italic>, and <italic>ATG7</italic> was consistent but there was no difference between the AS and control groups (<xref ref-type="fig" rid="F5">Figure&#x00A0;5E</xref>).</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Analysis and verification of m6A-Ferr-related signature genes using boxplot analysis, ROC curve, and an RT-PCR. <bold>(A)</bold> Boxplot analysis using the rank sum test for the GSE43292 dataset. <bold>(B)</bold> ROC curve for the GSE43292 dataset. <bold>(C)</bold> Box-and-whisker plot analysis using the rank sum test for the GSE100927 dataset. <bold>(D)</bold> ROC curve for the GSE100927 dataset. <bold>(E)</bold> Expression of the six genes in the AS and control samples using an RT-PCR.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g005.tif"/>
</fig>
</sec>
<sec id="s3f"><label>3.6</label><title>Single-gene GSEA of m6A-Ferr-related signature genes</title>
<p>To understand the biological function and the involved signaling pathways of the m6A-Ferr-related signature genes, GSEA was performed. The top 10 GO entries and KEGG pathways of the six genes are displayed in <xref ref-type="fig" rid="F6">Figures&#x00A0;6A&#x2013;F</xref>, <xref ref-type="fig" rid="F7">7A&#x2013;F</xref>. We found that these genes were involved in B-cell-mediated immunity, activated immune response, adaptive immune response, the T-cell receptor signaling pathway, the B-cell receptor signaling pathway, and autoimmune thyroid disease among other BP and pathways (<xref ref-type="fig" rid="F6">Figures&#x00A0;6A&#x2013;F</xref>, <xref ref-type="fig" rid="F7">7A&#x2013;F</xref>).</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Single-gene GSEA for m6A-Ferr-related signature genes. <bold>(A)</bold> Results of GO enrichment analysis for <italic>AGPAT3</italic> using the single-gene GSEA method (top 10). <bold>(B)</bold> GO enrichment results for <italic>ATG7</italic> using the single-gene GSEA method. <bold>(C)</bold> GO enrichment results for <italic>CDO1</italic> using the single-gene GSEA method. <bold>(D)</bold> GO enrichment results for <italic>CYBB</italic> using the single-gene GSEA method. <bold>(E)</bold> GO enrichment results for <italic>NOX4</italic> using the single-gene GSEA method. <bold>(F)</bold> GO enrichment results for <italic>SLC3A2</italic> using the single-gene GSEA method.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g006.tif"/>
</fig>
<fig id="F7" position="float"><label>Figure 7</label>
<caption><p>Single-gene GSEA for m6A-Ferr-related signature genes. <bold>(A)</bold> Results of KEGG enrichment analysis for <italic>AGPAT3</italic> using the single-gene GSEA method (top 10). <bold>(B)</bold> KEGG enrichment results for <italic>ATG7</italic> using the single-gene GSEA method. <bold>(C)</bold> KEGG enrichment results for <italic>CDO1</italic> using GSEA the single-gene method. <bold>(D)</bold> KEGG enrichment results for <italic>CYBB</italic> using the single-gene GSEA method. <bold>(E)</bold> KEGG enrichment results for <italic>NOX4</italic> using the single-gene GSEA method. <bold>(F)</bold> KEGG enrichment results for <italic>SLC3A2</italic> using the single-gene GSEA method.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g007.tif"/>
</fig>
</sec>
<sec id="s3g"><label>3.7</label><title>Immuno-infiltration analysis</title>
<p>Since the GSEA results suggested that the m6A-Ferr-related signature genes in AS were linked to immune-related functions, we then performed an immune infiltration analysis. By analyzing the ratio of 22 immune cells in the AS and control samples, an abundance map of immune cell infiltration proportions was constructed to demonstrate the immune cell content in the samples (<xref ref-type="fig" rid="F8">Figure&#x00A0;8A</xref>). A correlation heat map and <italic>p</italic>-value correlation heat map of the immune cell ratio are shown in <xref ref-type="fig" rid="F8">Figures&#x00A0;8B,C</xref>. A total of two types of immune cells (CD8&#x002B; T cells and activated CD4&#x002B; memory T cells) showed significant differences between the AS and control groups (<xref ref-type="fig" rid="F8">Figure&#x00A0;8D</xref>). The correlations of the 22 immune cells with the six m6A-Ferr-related signature genes were calculated and individually plotted in lollipop plots (<xref ref-type="fig" rid="F8">Figures&#x00A0;8E&#x2013;J</xref>). According to <italic>p</italic><sub>adj</sub> &#x003C;0.5 and &#x007C;cor&#x007C; &#x003E;0.3, naive B cells, CD8&#x002B; T cells, regulatory T cells (Tregs), and activated natural killer (NK) cells were positively correlated with <italic>CDO1</italic> and <italic>NOX4</italic> but negatively correlated with <italic>ATG7</italic>, <italic>CYBB</italic>, and <italic>SLC3A2</italic>. In addition, <italic>AGPAT3</italic> was negatively correlated with naive B cells, CD8&#x002B; T cells, and activated NK cells, and <italic>SLC3A2</italic> was positively correlated with activated CD4&#x002B; memory T cells.</p>
<fig id="F8" position="float"><label>Figure 8</label>
<caption><p>Immune infiltration analysis of atherosclerosis vs. control samples. <bold>(A)</bold> Ratio representation of immune infiltrating cells. <bold>(B)</bold> Correlation heatmap depicting proportions of immune cells. <bold>(C)</bold> <italic>p</italic>-value correlation matrix indicating significance levels among immune cell proportions. <bold>(D)</bold> Box plot comparing differences in immune cell content between the atherosclerosis and control groups. <bold>(E)</bold> Correlation analysis between immune cell content and <italic>AGPAT3</italic>. <bold>(F)</bold> Correlation analysis between immune cell content and <italic>ATG7</italic>. <bold>(G)</bold> Correlation analysis between immune cell content and <italic>CDO1</italic>. <bold>(H)</bold> Correlation analysis between immune cell content and <italic>CYBB</italic>. <bold>(I)</bold> Correlation analysis between immune cell content and <italic>NOX4</italic>. <bold>(J)</bold> Correlation analysis between immune cell content and <italic>SLC3A2</italic>.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1469805-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>AS is the primary cause of most cardiovascular events with the highest incidence rate and mortality among other causes worldwide (<xref ref-type="bibr" rid="B28">28</xref>). M6A modification plays an important role in various BP, including AS (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Ferroptosis is a regulated form of cell death attributed to an imbalance in the production and clearance of lipid peroxides caused by abundant cellular iron levels, which are also closely related to AS (<xref ref-type="bibr" rid="B8">8</xref>). It has been proven that the mRNA of various ferroptosis regulatory factors can be labeled with m6A modification. m6A participates in ferroptosis by regulating the mRNA stability, protein expression, and modification of multiple genes related to ferroptosis (<xref ref-type="bibr" rid="B15">15</xref>), and this has been demonstrated in the field of cancer research (<xref ref-type="bibr" rid="B31">31</xref>). The exploration of target genes for M6A-related ferroptosis in AS holds great potential. However, the link between M6A-related ferroptosis and AS has not yet been elucidated.</p>
<p>Through LASSO regression, this project screened three diagnostic genes for M6A-related ferroptosis in AS and constructed a diagnostic risk model for AS. We utilized WGCNA and LASSO analysis to identify six diagnostic genes associated with m6A-mediated ferroptosis in AS, namely <italic>AGPAT3</italic>, <italic>NOX4</italic>, <italic>CDO1</italic>, <italic>CYBB</italic>, <italic>ATG7</italic>, and <italic>SLC3A2</italic>. In addition, we also identified three m6A-related ferroptosis marker genes (<italic>NOX4</italic>, <italic>CDO1</italic>, and <italic>SLC3A2</italic>) using an RT-qPCR. Through the validation of expression levels, ROC mapping, single-gene GSEA, and immune infiltration analysis of these diagnostic genes, we revealed the relationship between these genes and AS at various levels. Subsequently, we constructed a diagnostic risk model for AS. This diagnostic risk model is beneficial for the clinical assessment of AS risk. Our findings demonstrate that all three m6A-Ferr-related characteristic genes have potential diagnostic value for AS. Several studies have presented evidence regarding the mechanisms and roles of these individual genes in AS. The production of ROS by <italic>NOX4</italic> is the molecular basis of AS, hypertension, and other chronic diseases (<xref ref-type="bibr" rid="B32">32</xref>). Furthermore, the active mediation of endothelial cell activation, dysfunction, and injury by <italic>NOX4</italic> contributes to the development of AS (<xref ref-type="bibr" rid="B33">33</xref>). Studies have indicated that <italic>CDO1</italic> may function as a co-activator of PPAR <italic>&#x03B3;</italic> in adipogenesis, potentially contributing to the pathogenesis of diseases associated with excessive adipose tissue such as AS (<xref ref-type="bibr" rid="B34">34</xref>). Promoting <italic>SLC3A2</italic>-related endothelial cell ferroptosis leads to endothelial cell damage and progression of AS plaque (<xref ref-type="bibr" rid="B35">35</xref>). Interestingly, the GO enrichment pathways found in this study include ferroptosis and chemical carcinogenesis-reactive oxygen species. These findings are consistent with the results of the related research mentioned above.</p>
<p>The progression of AS involves intricate interactions and phenotypic plasticity between blood vessels and immune cell lineages (<xref ref-type="bibr" rid="B36">36</xref>). Both the congenital and adaptive immune systems play a pivotal role in driving the chronic inflammation of arteries that is related to AS (<xref ref-type="bibr" rid="B37">37</xref>). The immune cells involved in AS include T cells, B cells, NK cells, Natural killer T cells, macrophages, monocytes, dendritic cells (DC), neutrophils, and mast cells (<xref ref-type="bibr" rid="B38">38</xref>). Our research findings indicate that the m6A-Ferr-related marker genes in AS are associated with immune functions. The results of the immune infiltration analysis revealed a positive correlation between immature B cells, CD8&#x002B; T cells, Tregs, and activated NK cells with <italic>CDO1</italic> and <italic>NOX4</italic>, while they showed a negative correlation with <italic>SLC3A2</italic>. In addition, <italic>SLC3A2</italic> was positively correlated with activated CD4&#x002B; memory T cells. In a mouse model of AS, antibody-mediated depletion of CD8&#x002B; T cells led to an improvement in AS. It has been observed that CD8&#x002B; T cells play a role in controlling monogenesis and macrophage accumulation in the early stages of AS (<xref ref-type="bibr" rid="B39">39</xref>). In addition, CD4&#x002B; T cells are commonly found in atherosclerotic plaques. There is substantial evidence indicating that helper T cell 1 (TH1) promotes AS, while Tregs have an anti-atherosclerotic effect. The roles of other TH cell subpopulations, follicular helper T cells, and T-cell subpopulations in AS remain unclear (<xref ref-type="bibr" rid="B40">40</xref>). Studies have demonstrated that <italic>CDO1</italic> redox immune-related genes can serve as indicators of the immune microenvironment (<xref ref-type="bibr" rid="B41">41</xref>). ROS generate <italic>NOX4</italic> enzymes, which are known to play a role in immune defense (<xref ref-type="bibr" rid="B42">42</xref>). The downregulation of <italic>SLC3A2</italic> contributes to immune evasion, and targeting <italic>SLC3A2</italic> can regulate the metabolic adaptability of immune cells and modulate cytokine production in human plasma such as dendritic cells (pDCs) (<xref ref-type="bibr" rid="B43">43</xref>). Successful immunotherapy for AS requires customization to address specific immune changes in different patient groups (<xref ref-type="bibr" rid="B44">44</xref>). In this study, three m6A-related ferroptosis genes were identified as potential biomarkers for AS. These genes are involved in BP and pathways such as B-cell-mediated immunity, activated immune response, adaptive immune response, the T-cell receptor signaling pathway, the B-cell receptor signaling pathway, and autoimmune thyroid disease. Currently, the treatment of AS has expanded from simple lipid-lowering and plaque stabilization to implementing immune prevention and control (<xref ref-type="bibr" rid="B45">45</xref>). This research provides a new perspective by revealing new immune mechanisms and cell type-specific pathways in AS.</p>
<p>In conclusion, our study demonstrates that all three diagnostic genes exhibit strong efficacy for risk diagnosis in AS. Compared to previous single genome or epigenetic analyses, the combined predictive model, composed of three diagnostic genes for m6A and ferroptosis, more accurately reflects the progression and prognosis of AS. In addition, this study investigated the correlation between three genes and immune infiltration related to AS, laying a theoretical foundation for immunotherapy in the field of AS. However, there are limitations in our research. First, this study did not elucidate the specific mechanisms by which three m6A-related ferroptosis genes regulate AS based on LASSO; further exploration is needed through animal experiments and the collection of clinical samples. Second, the AS datasets included in this study ignored the impact of population heterogeneity in different countries on the results.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by Medical Ethics Committee of the Second Affiliated Hospital of Kunming Medical University in China. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>MJ: Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft, Software, Formal Analysis. WZ: Writing &#x2013; review &#x0026; editing, Validation. LW: Writing &#x2013; review &#x0026; editing, Data curation. GZ: Funding acquisition, Writing &#x2013; review &#x0026; editing, Supervision, Project administration, Data curation.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province (YNWR-QNBJ-2020-238).</p>
</sec>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2024.1469805/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2024.1469805/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="Table1.xlsx"/></supplementary-material>
<supplementary-material id="SD2" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="Table2.xlsx"/></supplementary-material>
<supplementary-material id="SD3" content-type="local-data">
<media mimetype="application" mime-subtype="msword" xlink:href="Table3.doc"/></supplementary-material>
<supplementary-material id="SD4" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="Table4.xlsx"/></supplementary-material>
<supplementary-material id="SD5" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="Table5.xls"/></supplementary-material>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>BJ</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Gui</surname><given-names>DD</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>KJ</given-names></name><etal/></person-group> <article-title>Sestrin2 in atherosclerosis</article-title>. <source>Clin Chim Acta</source>. (<year>2021</year>) <volume>523</volume>:<fpage>325</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2021.10.019</pub-id><pub-id pub-id-type="pmid">34666031</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Maruf</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications</article-title>. <source>Theranostics</source>. (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>164</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.7150/thno.47841</pub-id><pub-id pub-id-type="pmid">33391468</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>T</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group>. <article-title>Insights into the role of N6-methyladenosine in ferroptosis</article-title>. <source>Biomed Pharmacother</source>. (<year>2023</year>) <volume>165</volume>:<fpage>115192</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2023.115192</pub-id><pub-id pub-id-type="pmid">37487443</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group>. <article-title>N6-Methyladenosine methyltransferase METTL3 promotes angiogenesis and atherosclerosis by upregulating the JAK2/STAT3 pathway via m6A reader IGF2BP1</article-title>. <source>Front Cell Dev Biol</source>. (<year>2021</year>) <volume>9</volume>:<fpage>731810</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.731810</pub-id><pub-id pub-id-type="pmid">34950654</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>The role of m6A ribonucleic acid modification in the occurrence of atherosclerosis</article-title>. <source>Front Genet</source>. (<year>2021</year>) <volume>12</volume>:<fpage>733871</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2021.733871</pub-id><pub-id pub-id-type="pmid">34603394</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><etal/></person-group> <article-title>METTL3 (methyltransferase like 3)-dependent N6-methyladenosine modification on braf mRNA promotes macrophage inflammatory response and atherosclerosis in mice</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2023</year>) <volume>43</volume>(<issue>5</issue>):<fpage>755</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.122.318451</pub-id><pub-id pub-id-type="pmid">36951060</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>W</given-names></name></person-group>. <article-title>The role of macrophage iron overload and ferroptosis in atherosclerosis</article-title>. <source>Biomolecules</source>. (<year>2022</year>) <volume>12</volume>(<issue>11</issue>):<fpage>1702</fpage>. <pub-id pub-id-type="doi">10.3390/biom12111702</pub-id><pub-id pub-id-type="pmid">36421722</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>S</given-names></name><name><surname>You</surname><given-names>J</given-names></name><name><surname>Zhi</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Ferroptosis: the potential value target in atherosclerosis</article-title>. <source>Cell Death Dis</source>. (<year>2021</year>) <volume>12</volume>(<issue>8</issue>):<fpage>782</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-021-04054-3</pub-id><pub-id pub-id-type="pmid">34376636</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group> <article-title>DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy</article-title>. <source>Cell Commun Signal</source>. (<year>2023</year>) <volume>21</volume>(<issue>1</issue>):<fpage>344</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-023-01298-8</pub-id><pub-id pub-id-type="pmid">38031118</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><etal/></person-group> <article-title>Regulation of m(6)A modification on ferroptosis and its potential significance in radiosensitization</article-title>. <source>Cell Death Discov</source>. (<year>2023</year>) <volume>9</volume>(<issue>1</issue>):<fpage>343</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-023-01645-1</pub-id><pub-id pub-id-type="pmid">37714846</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>914977</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.914977</pub-id><pub-id pub-id-type="pmid">36032107</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>N6-methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2</article-title>. <source>Cell Death Differ</source>. (<year>2023</year>) <volume>30</volume>(<issue>5</issue>):<fpage>1293</fpage>&#x2013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-023-01138-9</pub-id><pub-id pub-id-type="pmid">36828914</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Yin</surname><given-names>G</given-names></name><etal/></person-group> <article-title>N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells</article-title>. <source>Redox Biol</source>. (<year>2021</year>) <volume>47</volume>:<fpage>102151</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2021.102151</pub-id><pub-id pub-id-type="pmid">34607160</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Yi</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Huo</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>Targeting ferroptosis as a novel approach to alleviate aortic dissection</article-title>. <source>Int J Biol Sci</source>. (<year>2022</year>) <volume>18</volume>(<issue>10</issue>):<fpage>4118</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.72528</pub-id><pub-id pub-id-type="pmid">35844806</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>DS</given-names></name></person-group>. <article-title>Effects of DNA, RNA, and protein methylation on the regulation of ferroptosis</article-title>. <source>Int J Biol Sci</source>. (<year>2023</year>) <volume>19</volume>(<issue>11</issue>):<fpage>3558</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.85454</pub-id><pub-id pub-id-type="pmid">37497000</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>QR</given-names></name><name><surname>Li</surname><given-names>JW</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>FZ</given-names></name><name><surname>Zhao</surname><given-names>YN</given-names></name><etal/></person-group> <article-title>Establishment and validation of a ferroptosis-related lncRNA signature for prognosis prediction in lower-grade glioma</article-title>. <source>Front Neurol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>861438</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2022.861438</pub-id><pub-id pub-id-type="pmid">35832170</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Weng</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group>. <article-title>Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm</article-title>. <source>Front Aging Neurosci</source>. (<year>2022</year>) <volume>14</volume>:<fpage>973258</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2022.973258</pub-id><pub-id pub-id-type="pmid">36034129</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>G</given-names></name></person-group>. <article-title>Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis</article-title>. <source>PeerJ</source>. (<year>2020</year>) <volume>8</volume>:<fpage>e8390</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.8390</pub-id><pub-id pub-id-type="pmid">31988808</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>Venn diagrams in bioinformatics</article-title>. <source>Brief Bioinform</source>. (<year>2021</year>) <volume>22</volume>(<issue>5</issue>):<fpage>bbab108</fpage>. <pub-id pub-id-type="doi">10.1093/bib/bbab108</pub-id><pub-id pub-id-type="pmid">33839742</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Crucial gene identification in carotid atherosclerosis based on peripheral blood mononuclear cell (PBMC) data by weighted (gene) correlation network analysis (WGCNA)</article-title>. <source>Med Sci Monit</source>. (<year>2020</year>) <volume>26</volume>:<fpage>e921692</fpage>. <pub-id pub-id-type="doi">10.12659/MSM.921692</pub-id><pub-id pub-id-type="pmid">32160184</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group>. <article-title>Clusterprofiler: an R package for comparing biological themes among gene clusters</article-title>. <source>Omics</source>. (<year>2012</year>) <volume>16</volume>(<issue>5</issue>):<fpage>284</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group>. <article-title>The lasso method for variable selection in the cox model</article-title>. <source>Stat Med</source>. (<year>1997</year>) <volume>16</volume>(<issue>4</issue>):<fpage>385</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0258(19970228)16:4%3C385::AID-SIM380%3E3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">9044528</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>X</given-names></name><name><surname>Turck</surname><given-names>N</given-names></name><name><surname>Hainard</surname><given-names>A</given-names></name><name><surname>Tiberti</surname><given-names>N</given-names></name><name><surname>Lisacek</surname><given-names>F</given-names></name><name><surname>Sanchez</surname><given-names>JC</given-names></name><etal/></person-group> <article-title>pROC: an open-source package for R and S&#x002B; to analyze and compare ROC curves</article-title>. <source>BMC Bioinformatics</source>. (<year>2011</year>) <volume>12</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-12-77</pub-id><pub-id pub-id-type="pmid">21414208</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iasonos</surname><given-names>A</given-names></name><name><surname>Schrag</surname><given-names>D</given-names></name><name><surname>Raj</surname><given-names>GV</given-names></name><name><surname>Panageas</surname><given-names>KS</given-names></name></person-group>. <article-title>How to build and interpret a nomogram for cancer prognosis</article-title>. <source>J Clin Oncol</source>. (<year>2008</year>) <volume>26</volume>(<issue>8</issue>):<fpage>1364</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2007.12.9791</pub-id><pub-id pub-id-type="pmid">18323559</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>PC</given-names></name><name><surname>Harrell</surname><given-names>FE</given-names><suffix>Jr.</suffix></name><name><surname>van Klaveren</surname><given-names>D</given-names></name></person-group>. <article-title>Graphical calibration curves and the integrated calibration index (ICI) for survival models</article-title>. <source>Stat Med</source>. (<year>2020</year>) <volume>39</volume>(<issue>21</issue>):<fpage>2714</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/sim.8570</pub-id><pub-id pub-id-type="pmid">32548928</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Najeeb</surname><given-names>RM</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Zhong</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group>. <article-title>Upregulation of CENPM promotes hepatocarcinogenesis through multiple mechanisms</article-title>. <source>J Exp Clin Cancer Res</source>. (<year>2019</year>) <volume>38</volume>(<issue>1</issue>):<fpage>458</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-019-1444-0</pub-id><pub-id pub-id-type="pmid">31703591</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title>. <source>Methods</source>. (<year>2001</year>) <volume>25</volume>(<issue>4</issue>):<fpage>402</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group>. <article-title>Ferroptosis signaling and regulators in atherosclerosis</article-title>. <source>Front Cell Dev Biol</source>. (<year>2021a</year>) <volume>9</volume>:<fpage>809457</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.809457</pub-id><pub-id pub-id-type="pmid">34977044</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jian</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><etal/></person-group> <article-title>METTL14 Aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications</article-title>. <source>Theranostics</source>. (<year>2020</year>) <volume>10</volume>(<issue>20</issue>):<fpage>8939</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.7150/thno.45178</pub-id><pub-id pub-id-type="pmid">32802173</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>CS</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Chien</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>ML</given-names></name><name><surname>Yarmishyn</surname><given-names>AA</given-names></name><name><surname>Tsai</surname><given-names>PH</given-names></name><etal/></person-group> <article-title>METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2021</year>) <volume>118</volume>(<issue>7</issue>):<fpage>e2025070118</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2025070118</pub-id><pub-id pub-id-type="pmid">33579825</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>D</given-names></name><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Dixit</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Godugu</surname><given-names>B</given-names></name><etal/></person-group> <article-title>EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma</article-title>. <source>Mol Cell</source>. (<year>2023</year>) <volume>83</volume>(<issue>23</issue>):<fpage>4334</fpage>&#x2013;<lpage>4351.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2023.10.025</pub-id><pub-id pub-id-type="pmid">37979586</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ochoa</surname><given-names>CD</given-names></name><name><surname>Wu</surname><given-names>RF</given-names></name><name><surname>Terada</surname><given-names>LS</given-names></name></person-group>. <article-title>ROS signaling and ER stress in cardiovascular disease</article-title>. <source>Mol Aspects Med</source>. (<year>2018</year>) <volume>63</volume>:<fpage>18</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2018.03.002</pub-id><pub-id pub-id-type="pmid">29559224</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group>. <article-title>The human NOX4: gene, structure, physiological function and pathological significance</article-title>. <source>J Drug Target</source>. (<year>2015</year>) <volume>23</volume>(<issue>10</issue>):<fpage>888</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.3109/1061186X.2015.1036276</pub-id><pub-id pub-id-type="pmid">25950600</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2015</year>) <volume>458</volume>(<issue>1</issue>):<fpage>123</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.01.080</pub-id><pub-id pub-id-type="pmid">25637537</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(-/-)mice</article-title>. <source>Theranostics</source>. (<year>2023</year>) <volume>13</volume>(<issue>14</issue>):<fpage>4993</fpage>&#x2013;<lpage>5016</lpage>. <pub-id pub-id-type="doi">10.7150/thno.87968</pub-id><pub-id pub-id-type="pmid">37771765</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosquera</surname><given-names>JV</given-names></name><name><surname>Auguste</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>D</given-names></name><name><surname>Turner</surname><given-names>AW</given-names></name><name><surname>Hodonsky</surname><given-names>CJ</given-names></name><name><surname>Alvarez-Yela</surname><given-names>AC</given-names></name><etal/></person-group> <article-title>Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis</article-title>. <source>Cell Rep</source>. (<year>2023</year>) <volume>42</volume>(<issue>11</issue>):<fpage>113380</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2023.113380</pub-id><pub-id pub-id-type="pmid">37950869</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>P</given-names></name><name><surname>Orecchioni</surname><given-names>M</given-names></name><name><surname>Ley</surname><given-names>K</given-names></name></person-group>. <article-title>How the immune system shapes atherosclerosis: roles of innate and adaptive immunity</article-title>. <source>Nat Rev Immunol</source>. (<year>2022</year>) <volume>22</volume>(<issue>4</issue>):<fpage>251</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-021-00584-1</pub-id><pub-id pub-id-type="pmid">34389841</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kastrup</surname><given-names>M</given-names></name></person-group>. <article-title>The use of a psychiatric register in predicting the outcome &#x201C;revolving door patient&#x201D;. A nation-wide cohort of first time admitted psychiatric patients</article-title>. <source>Acta Psychiatr Scand</source>. (<year>1987</year>) <volume>76</volume>(<issue>5</issue>):<fpage>552</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1987.tb02918.x</pub-id><pub-id pub-id-type="pmid">3434327</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x00E4;fer</surname><given-names>S</given-names></name><name><surname>Zernecke</surname><given-names>A</given-names></name></person-group>. <article-title>CD8(&#x002B;) T cells in atherosclerosis</article-title>. <source>Cells</source>. (<year>2020</year>) <volume>10</volume>(<issue>1</issue>):<fpage>37</fpage>. <pub-id pub-id-type="doi">10.3390/cells10010037</pub-id><pub-id pub-id-type="pmid">33383733</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saigusa</surname><given-names>R</given-names></name><name><surname>Winkels</surname><given-names>H</given-names></name><name><surname>Ley</surname><given-names>K</given-names></name></person-group>. <article-title>T cell subsets and functions in atherosclerosis</article-title>. <source>Nat Rev Cardiol</source>. (<year>2020</year>) <volume>17</volume>(<issue>7</issue>):<fpage>387</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-020-0352-5</pub-id><pub-id pub-id-type="pmid">32203286</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name></person-group>. <article-title>Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer</article-title>. <source>Cancer Cell Int</source>. (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>365</fpage>. <pub-id pub-id-type="doi">10.1186/s12935-021-02038-z</pub-id><pub-id pub-id-type="pmid">34246261</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vermot</surname><given-names>A</given-names></name><name><surname>Petit-H&#x00E4;rtlein</surname><given-names>I</given-names></name><name><surname>Smith</surname><given-names>SME</given-names></name><name><surname>Fieschi</surname><given-names>F</given-names></name></person-group>. <article-title>NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology</article-title>. <source>Antioxidants (Basel</source>. (<year>2021</year>) <volume>10</volume>(<issue>6</issue>):<fpage>890</fpage>. <pub-id pub-id-type="doi">10.3390/antiox10060890</pub-id><pub-id pub-id-type="pmid">34205998</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grzes</surname><given-names>KM</given-names></name><name><surname>Sanin</surname><given-names>DE</given-names></name><name><surname>Kabat</surname><given-names>AM</given-names></name><name><surname>Stanczak</surname><given-names>MA</given-names></name><name><surname>Edwards-Hicks</surname><given-names>J</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters</article-title>. <source>Immunity</source>. (<year>2021</year>) <volume>54</volume>(<issue>11</issue>):<fpage>2514</fpage>&#x2013;<lpage>2530.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2021.10.009</pub-id><pub-id pub-id-type="pmid">34717796</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>DM</given-names></name><name><surname>Giannarelli</surname><given-names>C</given-names></name></person-group>. <article-title>Immune cell profiling in atherosclerosis: role in research and precision medicine</article-title>. <source>Nat Rev Cardiol</source>. (<year>2022</year>) <volume>19</volume>(<issue>1</issue>):<fpage>43</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-021-00589-2</pub-id><pub-id pub-id-type="pmid">34267377</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>A bibliometric analysis of T cell and atherosclerosis</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>948314</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.948314</pub-id><pub-id pub-id-type="pmid">36311729</pub-id></citation></ref></ref-list>
</back>
</article>